We are constantly talking with people from Novo Nordisk, Eli Lily and Sanofi Aventis - and other - big brands within the diabetes industry and the feedback thus far is that they love it.
We are not competing with any of the insulin pen manufacturers. We are simply providing an add-on product that allow their customers to keep using their pens with confidence.
Do the big pharma companies like you? Print
Created by: Laurel Gonzales
Modified on: Tue, 7 Apr, 2020 at 7:15 PM
Did you find it helpful? Yes No
Send feedbackSorry we couldn't be helpful. Help us improve this article with your feedback.